BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, November 16, 2025
Home
»
Authors
»
Jim Shrine
Articles by Jim Shrine
European Sector Rallying Cry: Comebacks, Consolidation
March 12, 2003
By
Jim Shrine
Companies Urged To Shore Up Until Sector Regains Favor
Sep. 11, 2002
By
Jim Shrine
Companies Urged To Shore Up Until Sector Regains Favor
Sep. 11, 2002
By
Jim Shrine
European Biotech Struggling, Industry Waiting For Upswing
Sep. 10, 2002
By
Jim Shrine
European Biotech Struggling, Industry Waiting For Upswing
Sep. 10, 2002
By
Jim Shrine
Finding Hot’ Biotech Investments Still Means Looking At Leaders
March 21, 2002
By
Jim Shrine
Finding Hot’ Biotech Investments Still Means Looking At Leaders
March 21, 2002
By
Jim Shrine
Investors In Tight Market Looking At Hybrid Platform/Product Firms
March 20, 2002
By
Jim Shrine
Investors In Tight Market Looking At Hybrid Platform/Product Firms
March 20, 2002
By
Jim Shrine
Large-Cap Companies Doing Well In Maturing Industry s Bifurcation
Jan. 1, 1999
By
Jim Shrine
Previous
1
2
…
18
19
20
21
22
23
24
25
26
Next